EXOSOMAX
EXOSOMAX Research-quality Exosomes are produced by Exodus Bio using their proprietary EXODUS isolation technology in California — the same high-purity, high-yield standards developed and required for Exodus Bio’s own groundbreaking research.
EXOSOMAX Day Zero Exosomes are derived from ethically sourced human umbilical cord mesenchymal stem cells isolated from Wharton’s Jelly. Each batch is supported by a formal umbilical cord traceability management process and multi-dimensional quality testing that includes biosafety evaluation, screening for common pathogens, endotoxin quantification, and systemic allergy testing.
EXOSOMAX Powered by EXODUS EV enrichment and purification technology delivers higher-purity exosomes with a particle-to-protein ratio of 5.0E+8 and above—far exceeding the International Society for Extracellular Vesicles (ISEV) standard of 1.0E+8. Impurity and protein removal efficiency exceeds 99%, resulting in greater potency and more powerful efficacy.
EXOSOMAX is a skincare product and not a drug. It is not intended to prevent, treat, or cure diseases or medical conditions
EXOSOMAX UNMatched PURITY
With the EXODUS® exosome enrichment and purification technology platform the purity of exosomes is higher, with a particle-to-protein ratio of 5.0E+8 and above, far exceeding the extracellular vesicle association standard. The removal efficiency of impurities and proteins is >99.9%, resulting in more powerful efficacy.
ethically sourced AND TESTED
DAY ZERO EXOSOMES
EXOSOMAX Day Zero Exosomes are derived from ethically sourced human umbilical cord mesenchymal stem cells isolated from Wharton’s Jelly. Each batch is supported by a formal umbilical cord traceability management process and undergoes multi-dimensional quality testing, including biosafety evaluation, screening for common pathogens, endotoxin quantification, and systemic allergy testing. The purification process removes more than 99% of residual culture-media proteins, supporting use across medical aesthetics, and skincare
Patented lyophilization
The double-layer membrane lyophilization protection system preserves exosome structure with high integrity and retains key bioactive components — proteins, lipids, and nucleic acids. After lyophilization and reconstitution, morphology remains intact and activity is maximized.
powered by exodus bio
EXODUS Bio is a leader in upstream exosome technology, with recognition that includes publication in Nature Methods and endorsements from Nobel Prize–winning cell biologist Dr. Randy Schekman, whose foundational work on vesicle trafficking shaped modern understanding of extracellular vesicles. Independent evaluations have shown that the company’s EXODUS system significantly outperforms traditional separation methods in purity and efficiency.
EXODUS system significantly outperforms traditional separation methods in purity and efficiency. The proprietary EXODUS platform — first fully automated system for exosome purification — uses dual-membrane nanofiltration that combines negative pressure oscillation (NPO) and ultrasonic harmonic oscillation (HO). This process rapidly removes free nucleic acids and residual proteins while a nanoporous membrane precisely intercepts intact exosomes, enabling highly efficient purification and enrichment.These principles and equipment support production of some of the purest, most consistent research-grade exosomes available — advancing biomedical research, and high-quality applications in aesthetics and regenerative science.
Exosomax: Research quality Exosomes
EXOSOMAX IS MADE IN SAN JOSE, CA BY BAY EXOSOMES INC. AN EXODUS COMPANY
EXOSOMAX is a skincare product and not a drug. It is not intended to prevent, treat, or cure diseases or medical conditions
